Industry Collaborations

Collaborate with JHU Researchers


The founding mission of the Johns Hopkins University calls for the institution to bring the benefits of discovery to the world. Through strategic industry collaborations, Johns Hopkins researchers have translated discoveries into real-world applications.

JHTV’s active industry collaborations span from basic science and clinical research to product development and data analytics. Take a look at a sampling of our ongoing collaborations below.

 

Abbvie

AbbVie

Type: Pre-clinical/Clinical
Area: Oncology
Contact: Dave Greenwald
Read more: This long-term collaboration funds Johns Hopkins research that facilitates the identification of new targets, technologies, biomarkers and therapeutics that have the potential to advance the treatment of hematological malignancies and solid tumors.

 

Bayer

Bayer

Type: Pre-clinical
Area: Ophthalmology
Contact: Amy House
Read more: Focusing specifically on back of the eye diseases, this long-term collaboration funds basic and translational research that could lead to the discovery and development of ophthalmic therapies.

 

Celgene

Celgene

Type: Pre-clinical/Clinical
Area: Oncology
Contact: Dave Greenwald, Sean Evans
Read more: As part of a multi-institution effort with Celgene, The Johns Hopkins University joined the University of Pennsylvania, Columbia University and Mt. Sinai in a collaboration focused on the development of anti-cancer drugs.

 

GSK DPAC Program

GSK DPAC Program

Type: Pre-clinical
Area: Small molecule drug development
Contact: Sean Evans
Read more: GlaxoSmithKline’s DPAc program allows Johns Hopkins researchers and GSK to collaborate for the purpose of translating innovative research into medicines that benefit patients.

 

MedImmune

MedImmune

Type: Pre-clinical
Area: Multiple
Contact: Helen Montag, Mary Beth Thanhouser
Read more: This long-term collaborative relationship with MedImmune, AstraZeneca’s global biologics research and development arm, spans a variety of therapeutic areas.

 

Mitsubishi Tanabe Pharma

Mitsubishi Tanabe Pharma

Type: Pre-clinical
Area: CNS, Psychiatric
Contact: Helen Montag
Read more: Through funding for basic and translational research, this long-term collaboration aims to discover and develop therapeutics for disorders related to the central nervous system.

 

miDiagnostics

miDiagnostics

Type: Pre-clinical
Area: POC diagnostics
Contact: Sean Evans
Read more: A venture created from a collaboration between The Johns Hopkins University and the Belgian nanoelectronics research institute imec, miDiagnostics aims to facilitate more efficient health care at any point of need through accurate and integrated diagnostic devices and data.

 

OurCrowd Qure

OurCrowd Qure

Type: Clinical
Area: Digital Health
Contact: Mary Beth Thanhouser
Read more: The world’s first digital health fund, OurCrowd Qure is a collaboration between OurCrowd and The Johns Hopkins University that brings Israeli health IT startups to Johns Hopkins for clinical trials and technology validation.

 

Pfizer Centers for Therapeutic Innovation

Pfizer Centers for Therapeutic Innovation

Type: Pre-clinical
Area: Multiple
Contact: Sean Evans
Read more: This long-term collaboration with Pfizer’s Centers for Therapeutic Innovation (CTI) aims to identify large- and small-molecule compounds with activity in a pathway or target of interest to a Johns Hopkins researcher and to CTI.